Adherium Limited (ADR.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -11.56 Million AUD | -16.69% |
| 2023 | -9.91 Million AUD | 7.38% |
| 2022 | -12.65 Million AUD | -3.55% |
| 2021 | -12.74 Million AUD | -42.3% |
| 2020 | -8.46 Million AUD | 24.19% |
| 2019 | -11.38 Million AUD | -20.17% |
| 2018 | -10.14 Million AUD | 31.85% |
| 2017 | -13.83 Million AUD | -110.75% |
| 2016 | -6.56 Million AUD | -497.2% |
| 2015 | -1.09 Million AUD | 51.27% |
| 2014 | -2.25 Million AUD | -1612.19% |
| 2013 | -131.72 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | -1.33% |
| 2024 Q4 | -6.68 Million AUD | 0.0% |
| 2024 Q2 | -4.78 Million AUD | 0.0% |
| 2023 FY | - AUD | 7.38% |
| 2023 Q4 | -4.08 Million AUD | 0.0% |
| 2023 Q2 | -5.82 Million AUD | 0.0% |
| 2022 Q4 | -4.88 Million AUD | 0.0% |
| 2022 FY | - AUD | -3.55% |
| 2022 Q2 | -5 Million AUD | 0.0% |
| 2021 Q2 | -8.17 Million AUD | 0.0% |
| 2021 Q4 | -4.56 Million AUD | 0.0% |
| 2021 FY | - AUD | -42.3% |
| 2020 Q2 | -3.4 Million AUD | 0.0% |
| 2020 Q4 | -5.15 Million AUD | 0.0% |
| 2020 FY | - AUD | 24.19% |
| 2019 FY | - AUD | -20.17% |
| 2019 Q4 | -2.98 Million AUD | 0.0% |
| 2019 Q2 | -8.53 Million AUD | 0.0% |
| 2018 Q4 | -4.41 Million AUD | 0.0% |
| 2018 Q2 | -5 Million AUD | 0.0% |
| 2018 FY | - AUD | 31.85% |
| 2017 Q2 | -5.04 Million AUD | 0.0% |
| 2017 FY | - AUD | -110.75% |
| 2017 Q4 | -8.14 Million AUD | 0.0% |
| 2016 FY | - AUD | -497.2% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | - AUD | 51.27% |
| 2015 Q3 | - AUD | 0.0% |
| 2014 FY | - AUD | -1612.19% |
| 2013 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 67.936% |
| Aroa Biosurgery Limited | -7.36 Million AUD | -57.124% |
| Atomo Diagnostics Limited | -5.42 Million AUD | -113.229% |
| Anteris Technologies Ltd | -66.9 Million AUD | 82.715% |
| Control Bionics Limited | -5.15 Million AUD | -124.195% |
| CardieX Limited | -6.71 Million AUD | -72.299% |
| Compumedics Limited | 2.78 Million AUD | 514.646% |
| Cochlear Limited | 579.5 Million AUD | 101.996% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -231.189% |
| Cyclopharm Limited | -3.03 Million AUD | -281.049% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -453.004% |
| Nova Eye Medical Limited | -5.97 Million AUD | -93.418% |
| HeraMED Limited | -3.97 Million AUD | -191.145% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 47.123% |
| ImpediMed Limited | -22.05 Million AUD | 47.556% |
| InhaleRx Limited | -1.41 Million AUD | -718.003% |
| LBT Innovations Limited | -4.04 Million AUD | -185.613% |
| Micro-X Limited | -14.35 Million AUD | 19.417% |
| Neurotech International Limited | -8.24 Million AUD | -40.277% |
| OncoSil Medical Limited | -11.97 Million AUD | 3.438% |
| PolyNovo Limited | 5.17 Million AUD | 323.684% |
| Respiri Limited | -7.04 Million AUD | -64.037% |
| SomnoMed Limited | -2.32 Million AUD | -396.625% |
| Universal Biosensors, Inc. | -9.09 Million AUD | -27.216% |
| Uscom Limited | -1.5 Million AUD | -666.209% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -135.175% |